Rennova Health, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RNVA research report →
Companywww.rennovahealth.com
Rennova Health, Inc. , together with its subsidiaries, provides health care services in the United States. As of December 31, 2021, it owns one operating hospital in Oneida, Tennessee; an acute care hospital and a physician's practice in Jamestown, Tennessee; and a rural clinic in Williamsburg, Kentucky.
- CEO
- Seamus Lagan
- IPO
- 1995
- Employees
- 96
- HQ
- West Palm Beach, FL, US
Price Chart
Valuation
- Market Cap
- $4.31M
- P/E
- -0.42
- P/S
- 0.23
- P/B
- -0.09
- EV/EBITDA
- 11.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 59.46%
- Op Margin
- 7.31%
- Net Margin
- -41.36%
- ROE
- 23.45%
- ROIC
- -7.24%
Growth & Income
- Revenue
- $18.69M · 43.34%
- Net Income
- $-7,729,161 · -134.71%
- EPS
- $-0.00 · 99.40%
- Op Income
- $1.37M
- FCF YoY
- 1297.63%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.05
- Avg Volume
- 973.53K
Get TickerSpark's AI analysis on RNVA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 17, 21 | Diamantis Christopher Eric | other | 0 |
| Aug 27, 21 | Diamantis Christopher Eric | other | 95,000,000 |
| Aug 27, 21 | Diamantis Christopher Eric | other | 47,500,000 |
| Aug 27, 21 | Diamantis Christopher Eric | other | 570 |
| Apr 8, 19 | Immordino Jonathan | other | 0 |
| Jul 23, 18 | Lagan Seamus | other | 250,000 |
| Jul 1, 18 | McLennan Marlene | other | 0 |
| Mar 6, 18 | Beach John | other | 3,333,333 |
| Mar 6, 18 | BLUM GARY L | other | 3,333,333 |
| Mar 6, 18 | Langley Trevor | other | 3,333,333 |
Our RNVA Coverage
We haven't published any research on RNVA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RNVA Report →